Desq Long
Sign in

Company

EXOZYMES INC.

EXOZ · CIK 0002010788

SEC FORM 4
$30.32

EXOZYMES INC. (EXOZ)

Purchase of 4 shares at $7.58 per share.

Reporting Person Heltzen Michael · Officer Title Chief Executive Officer · Transaction Code P

Traded Aug 26, 2026 · Disclosed Sep 2, 2026FILED +7 DAYS

Source: SEC Form 4 · 0001493152-26-041290 · filed 2026-09-02 · View filing →

SEC FORM 4
$1,844.85

EXOZYMES INC. (EXOZ)

Purchase of 251 shares at $7.35 per share.

Reporting Person Heltzen Michael · Officer Title Chief Executive Officer · Transaction Code P

Traded Aug 26, 2026 · Disclosed Sep 2, 2026FILED +7 DAYS

Source: SEC Form 4 · 0001493152-26-041290 · filed 2026-09-02 · View filing →

SEC FORM 4
$1,900.00

EXOZYMES INC. (EXOZ)

Purchase of 250 shares at $7.60 per share.

Reporting Person Heltzen Michael · Officer Title Chief Executive Officer · Transaction Code P

Traded Aug 26, 2026 · Disclosed Sep 2, 2026FILED +7 DAYS

Source: SEC Form 4 · 0001493152-26-041290 · filed 2026-09-02 · View filing →

SEC FORM 4
$1,880.00

EXOZYMES INC. (EXOZ)

Purchase of 250 shares at $7.52 per share.

Reporting Person Heltzen Michael · Officer Title Chief Executive Officer · Transaction Code P

Traded Aug 25, 2026 · Disclosed Sep 2, 2026FILED +8 DAYS

Source: SEC Form 4 · 0001493152-26-041290 · filed 2026-09-02 · View filing →

SEC FORM 4
$750.00

EXOZYMES INC. (EXOZ)

Purchase of 100 shares at $7.50 per share.

Reporting Person Heltzen Michael · Officer Title Chief Executive Officer · Transaction Code P

Traded Aug 25, 2026 · Disclosed Sep 2, 2026FILED +8 DAYS

Source: SEC Form 4 · 0001493152-26-041290 · filed 2026-09-02 · View filing →

SEC FORM 4
$56,582.40

EXOZYMES INC. (EXOZ)

Acquisition (code A) of 8,841 shares at $6.40 per share.

Reporting Person Heltzen Michael · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 19, 2026 · Disclosed Sep 2, 2026FILED +14 DAYS

Source: SEC Form 4 · 0001493152-26-041290 · filed 2026-09-02 · View filing →

SEC FORM 4
—

EXOZYMES INC. (EXOZ)

Acquisition (code M) of 32,964 shares; price not stated (see filing).

Reporting Person Korman Tyler Paz · Officer Title Chief Scientific Officer · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 25, 2026FILED +6 DAYS

Source: SEC Form 4 · 0001493152-26-040116 · filed 2026-08-25 · View filing →

SEC FORM 4
—

EXOZYMES INC. (EXOZ)

Acquisition (code M) of 19,612 shares; price not stated (see filing).

Reporting Person Perriman Damien Alan · Officer Title Chief Commercial Officer · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 25, 2026FILED +6 DAYS

Source: SEC Form 4 · 0001493152-26-040129 · filed 2026-08-25 · View filing →